Gilead Says It Will Launch Generic Versions Of Hepatitis C Drugs.

September 25, 2018

Modern Healthcare (9/24, Kacik, Subscription Publication) reports Gilead Sciences announced Monday that it plans to launch generic versions of its top hepatitis C drugs, Harvoni (ledipasvir) and Epculsa (sofosbuvir). Gilead’s CEO John Milligan explained,...